Low-dose aspirin should not be used for primary prevention in older people as it has no benefit and increases the risk of major bleeding events, an Australian RCT has shown. Among the many outcomes assessed in the five-year Aspirin in Reducing Events in the Elderly (ASPREE) trial, Australian researchers showed that low-dose aspirin did not reduce ...
ASPREE shows no stroke benefit for low dose aspirin and some risk of bleeding
By Michael Woodhead
19 Sep 2018